Global COPD and Asthma Devices Market 2022-2028

Description

List of Tables

Global COPD and Asthma Devices Market Size, Share & Trends Analysis by Product type (Inhaler, Nebulizer, Humidifier And Dehumidifier, Respiratory Mask, Oxygen Concentrator), By End-User (Hospitals, Home Care) Forecast Period (2022-2028)

The global COPD and asthma devices market is anticipated to grow at a considerable CAGR of 9.7% during the forecast period. A rising incidence of tobacco consumption has been witnessed increasing the number of cases of COPD. COPD is related to cigarette smoking and COPD is a group of diseases that is caused by blockage of airflow and breathing-related problems. Therefore, smokers are more prone to COPD. In a survey conducted by the WHO in 2019, up to half of all smokers will die from tobacco-related illnesses including cancer, lung, and heart disease by 2030. In 2019, in China, there were more than 300 million smokers which are 1/3 of the world's total. More than half of the adults are smokers in China. In addition, one in every third of cigarettes in the world is smoked in China. However, high cost is one of the restraining factors that is having an adverse effect to give the proper and effective treatment for patients suffering from COPD and asthma as higher health cost increases the financial burden on patients. As the level of disease severity increases, it also leads to an increase in costs related to maintenance therapy along with the treatment of COPD and asthma. Moreover, the presence of multiple-inhaler use is having more prices as it is used for giving the treatment of COPD and asthma due to its increased complexity offered by additional inhalers which would further raise the financial burden of the patients.

The global COPD and asthma devices market is segmented based on the product type and end-user. Based on the product type, the market is segmented into the inhaler, nebulizer, humidifier and dehumidifier, respiratory mask, and an oxygen concentrator. The inhaler is expected to have a major market share during the forecast period with a significant growth rate. By end-user, the market has been divided into hospitals & clinics, and home care. Homecare is expected to have a major market share due to the high usage of inhalers by the patient on regular basis.

The global COPD and asthma devices market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the North American regional market is expected to cater to considerable growth during the forecast period.

The major companies serving the global COPD and asthma devices market include 3M Co., AstraZeneca PLC, Becton Dickinson & Co., Boehringer Ingelheim International GmbH, and Teva Pharmaceuticals Industries Ltd. among others. Market players are constantly focusing on gaining major market share by adopting strategies such as mergers & acquisitions, product launches, partnerships, and collaboration. For instance, in January 2021, a product named Symbicort Turbuhalerwas approvedfor mild, moderate, and severe asthma for people aged 12 years and above.

Research Methodology

The market study of the global COPD and Asthma Devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global COPD and Asthma DevicesMarket Research and Analysis by Product Type

2. Global COPD and Asthma DevicesMarket Research and Analysis by End-User

The Report Covers

Comprehensive research methodology of the global COPD and Asthma Devices market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the COPD and Asthma Devices market.
Insights about market determinants that are stimulating the global COPD and Asthma Devices s market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2019481

Category- Medical Devices

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global COPD and Asthma Devices Market
Recovery Scenario of Global COPD and Asthma Devices Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global COPD and Asthma Devices Market by Product Type
- 4.1.1. Biochips Respiratory Inhalers
- 4.1.2. Respiratory Nebulizers
- 4.1.3. Respiratory Humidifiers and Dehumidifier
- 4.1.4. Respiratory Oxygen Concentrators
- 4.1.5. Other Respiratory Products (Respiratory Masks)
4.2. Global COPD and Asthma Devices Market by End-User
- 4.2.1. Hospitals
- 4.2.2. Home Care

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. Abbott Laboratories, Inc.
6.2. 3M Co.
6.3. Adamis Pharmaceuticals Corp.
6.4. Adherium Ltd.
6.5. Aradigm Corp.
6.6. Aristopharma Ltd.
6.7. AstraZeneca PLC
6.8. Boehringer Ingelheim International GmbH
6.9. Becton Dickinson & Co. (CareFusion)
6.10. ChiesiFarmaceutici SPA
6.11. Cipla Inc.
6.12. Cohero Health, Inc.
6.13. DeVilbiss Healthcare LLC
6.14. Gerresheimer AG
6.15. GE Healthcare
6.16. Gilbert Technologies BV
6.17. GlaxoSmithKline PLC
6.18. Koninklijke Philips NV
6.19. MedisolLifescience Pvt. Ltd.
6.20. Mylan NV
6.21. Novartis AG
6.22. Orion Corp.
6.23. Peptinnovate Ltd.
6.24. Smith Medical, Inc.
6.25. Sunovion Pharmaceuticals Inc.
6.26. Teicos Pharma Ltd.
6.27. Teva Pharmaceuticals Industries Ltd.
6.28. Verona Pharma PLC